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of transplantation (both living donor and cadaver). EffortsEnd-stage renal disease in sub-Saharan and South Africa. The
should be made to optimize therapy of renal disease and renalmajor health problems in Africa are AIDS, tuberculosis, ma-
failure globally and particularly in developing countries. Strate-laria, gastroenteritis and hypertension; hypertension affects
gies should be developed to screen for and manage conditionsabout 20% of the adult population. Renal disease, especially
such as hypertension and diabetes mellitus at the primary health-glomerular disease, is more prevalent in Africa and seems to
care level in an effort to decrease the incidence of chronic re-be of a more severe form than that found in Western countries.
nal failure. Increasingly, health is influenced by social and eco-The most common mode of presentation is the nephrotic syn-
nomic circumstances. Any improvements in health thus demanddrome, with the age of onset at five to eight years. It is estimated
integrated, comprehensive action against all the determinantsthat 2 to 3% of medical admissions in tropical countries are
of ill health.due to renal-related complaints, the majority being the glomer-
ulonephritides. There are no reliable statistics for ESRD in all
African countries. Statistics of the South African Dialysis and
Transplant Registry (SADTR) reflect the patients selected for
Africa is a vast continent, extending over 30 millionrenal replacement therapy (RRT) and do not accurately reflect
square km and comprising 53 countries and approximatelythe etiology of chronic renal failure (CRF), where public sector
state facilities will offer RRT only to patients who are eligible 760 million people. Many millions live in overcrowded and
for a transplant. In 1994, glomerulonephritis was recorded as unhygienic conditions, where lack of clean water and in-
the cause of ESRD in 1771 (52.1%) and hypertension in 1549 adequate sanitation foster breeding grounds for infec-
(45.6%) of patients by the SADTR. In a six-year study of 3632
tious diseases. Infectious diseases are the world’s lead-patients with ESRD, based on SADTR statistics, hypertension
ing cause of death, 43% in the developing world comparedwas reported to be the cause of ESRD in 4.3% of whites,
34.6% of blacks, 20.9% mixed race group and 13.8% of Indians. to 1.2% in the developed world [1]. Diseases that had
Malignant hypertension is an important cause of morbidity and seemed to be controlled such as tuberculosis and malaria
mortality among urban black South Africans, with hyperten- have become a major health problem, with problems ofsion accounting for 16% of all hospital admissions. In a ten-
resistance to therapy. New diseases, such as AIDS, haveyear study of 368 patients with chronic renal failure in Nigeria,
reached epidemic proportions especially in sub-Saharanthe etiology of renal failure was undetermined in 62%. Of the
remaining patients whose etiology was ascertained, hyperten- Africa.
sion accounted for 61%, diabetes mellitus for 11% and chronic Per capita expenditure per year on healthcare ranges
glomerulonephritis for 5.9%. Patients with CRF constituted from 9 US dollars (Nigeria), 29 US dollars (Senegal),10% of all medical admissions in this center. Chronic glomeru-
100 US dollars (North Africa) and 158 US dollars (Southlonephritis and hypertension are principal causes of CRF in
Africa); the healthcare expenditure in Europe is approxi-tropical Africa and East Africa, together with diabetes mellitus
and obstructive uropathy. The availability of dialysis and trans- mately 2000 US dollars. Increasingly, health is influenced
plantation is quite variable in Africa: treatment rates in North by social and economic circumstances. Any improve-
Africa are 30 to 186.5 per million population (pmp) in countries
ments in health thus demand integrated, comprehensivewith more established programs: Algeria 78.5; Egypt 129.3;
action against all the determinants of ill health.Libya 30; Morocco 55.6; Tunisia 186.5 pmp. In South Africa,
treatment rates of 99 pmp were reported; Dialysis and trans-
plant programs in the rest of Africa are dependent on the
MAJOR HEALTH PROBLEMSavailability of funding and donors. Services are still predomi-
nantly urban and therefore generally inaccessible to the poorer, The major health problems in Africa are AIDS, tuber-
less educated rural patient. There is not enough money for culosis, malaria, gastroenteritis and hypertension. Hy-healthcare in the developing world, particularly for expensive
pertension affects about 20% of the adult population,and chronic treatment such as RRT. The goal should be to
an estimated 691 million people worldwide. It is one ofhave a circumscribed chronic dialysis program, with as short
a time on dialysis as possible, and to increase the availability the major risk factors for heart disease, stroke and kidney
failure. Diabetes mellitus may present one of the most
daunting challenges in the future. The number is cur-Key words: Africa and kidney disease, nephrotic syndrome, CAPD,
IPD, hemodialysis, hypertension, diabetes mellitus. rently estimated to be about 135 million and it is expected
to rise to about 300 million by the year 2025. While the 2003 by the International Society of Nephrology
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Table 1. Renal replacement therapy (RRT) in Sub-Saharanincrease in cases will exceed 40% in developed countries,
Africa (1994–1998)
it is anticipated to be in the order of 170% in developing
HD CAPD IPD Tx Dialysis Txcountries [1].
N patients pmp
Namibia 7 20PATTERNS OF RENAL DISEASE Zimbabwe 59 38 4
Botswana 4 3There is a wide variation in the patterns of renal dis-
Sudan 200 150 300ease in different geographical areas. Accurate and com- Congo 2 30 6
prehensive statistics are lacking. Renal disease, espe- Kenya 80 20 variable
South Africa 1077 448 variable 299 99 8.7cially glomerular disease, is more prevalent in Africa
Abbreviations are: HD, hemodialysis; CAPD, continuous ambulatory perito-and seems to be of a more severe form than that found
neal dialysis; IPD, intermittent peritoneal dialysis; Tx, transplantation; pmp, perin Western countries [2]. The most common mode of million population.
presentation is the nephrotic syndrome, with the age of
onset at five to eight years. It is estimated that 2 to 3%
of medical admissions in tropical countries are due to
mixed race patients; glomerulonephritis in 25% blacks,renal-related complaints, the majority being the glomer-
white and Indians and 33% of mixed race patients; anal-ulonephritides, which in East and Central Africa are
gesic nephropathy occurred predominantly in whites, caus-characterized by poor response to treatment and pro-
ing end-stage renal failure in 33% [6]. In contrast, a studygression to renal failure. Nephrotic syndrome accounts
of ESRD in predominantly white patients in Johannes-for 0.5% of all hospital admissions in Zimbabwe; 0.2%
burg showed that glomerulonephritis occurred in 32%,in Kwa Zulu Natal, South Africa; 2% in Uganda and
analgesic nephropathy in 21% and hypertension in 2%2.4% in Nigeria.
[7]. In a six year study of 3632 patients with end-stageThe pattern of renal disease in South Africa has been
renal failure, based on SADTR statistics, hypertensionreviewed recently [3]. Glomerulonephritis in South Af-
was reported to be the cause of ESRD in 4.3% of whites,rica is characterized by a higher frequency in blacks, a
34.6% of blacks, 20.9% mixed race group and 13.8% oflesser frequency in Indians and a lower frequency in
Indians, with 15.9% of cases of essential hypertensionwhites. It appears that the milieu of chronic parasitic,
resulting in end-stage renal failure and 57% of thesebacterial and viral infections predisposes to an increased
undergoing malignant change [8].prevalence of glomerulonephritis.
Prevalence studies in the adult black population of
Natal showed that hypertension was present in 25% of
CHRONIC RENAL FAILURE urban Zulus, 17.2% of whites and 14% of Indians. Malig-
Several studies have demonstrated the high incidence nant hypertension is an important cause of morbidity and
of chronic renal disease among black Americans. Unfor- mortality among urban black South Africans, with hyper-
tunately, there are no reliable statistics in all African tension accounting for 16% of all hospital admissions.
countries. However, there is a general impression that In a ten-year study of 368 patients with chronic renal
it is at least three to four times more frequent than in failure in Nigeria, the etiology of renal failure was unde-
more developed countries; this is substantiated by analy- termined in 62%. Of the remaining patients whose etiol-
sis of the causes of death, reporting that uremia accounts ogy was ascertained, hypertension accounted for 61%,
for 1 to 1.5% of total annual deaths among Egyptians, diabetes mellitus for 11% and chronic glomerulonephri-
both in the predialysis era and for two decades thereafter tis for 5.9% [9]. Patients with chronic renal failure consti-
[4]. These figures are comparable with those of other coun- tuted 10% of all medical admissions in this center.
tries in the region with similar socioeconomic standards. Chronic glomerulonephritis and hypertension are princi-
Statistics of the South African Dialysis and Transplant pal causes of chronic renal failure in tropical Africa and
Registry (SADTR) reflect the patients selected for renal East Africa, together with diabetes mellitus and obstruc-
replacement therapy (RRT) and do not accurately reflect tive uropathy [10].
the etiology of chronic renal failure (CRF), as few pa-
tients with diabetic end-stage renal disease (ESRD) are
RENAL REPLACEMENT THERAPY IN AFRICAoffered dialysis or transplantation because of associated
The availability of dialysis and transplantation is quiteco-morbid conditions. In 1994, glomerulonephritis was
variable in Africa. Table 1 shows the small number ofrecorded as the cause of ESRD in 1771 (52.1%) of pa-
patients on treatment in southern and sub-Saharan Af-tients and hypertension in 1549 (45.6%) of patients by
rica; in comparison, treatment rates in North Africa arethe SADTR [5]. In a study of 394 patients from 1974 to
30 to 186.5 per million population (pmp) in countries with1981 in Natal, hypertension was reported as the cause
of ESRD in 32% of blacks, 24% of Indians and 29% of more established programs: Algeria 78.5; Egypt 129.3;
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Libya 30; Morocco 55.6; Tunisia 186.5 pmp. Services Cameroon offers all modalities of dialytic support to
limited numbers of patients, depending on funding.are still predominantly urban and therefore generally
inaccessible to the poorer, less educated rural patient. Cote d’Ivoire has a few hemodialysis and renal trans-
plant patients, with the patients being transplanted in
other countries.
SOUTH AFRICA Ethiopia has hemodialysis and peritoneal dialysis fa-
The last reliable report of the SADTR in 1994 showed cilities for acute renal failure.
that 3399 patients (99 per million population) were alive
on treatment for end-stage renal failure, with 754 new
PROPOSAL FOR TREATMENT OF RENALpatients having commenced therapy in 1994, hospital
FAILURE IN AFRICAhemodialysis (HD) in 1051 patients (30%), home HD in
Ideally, every end-stage chronic renal failure patient26 patients, continuous ambulatory peritoneal dialysis
should have access to dialysis. The reality is that there is(CAPD) in 448 patients, and intermittent peritoneal dial-
not enough money for healthcare in the developingysis (IPD) in 13 patients. Two hundred and ninety nine
world, particularly for expensive and chronic treatmenttransplants were performed in 1994, 253 from cadaver
such as renal replacement therapy. The goal should bedonors, 35 from living related donors and 11 from unre-
to have a circumscribed chronic dialysis program, with aslated donors, with a total of 1578 functioning grafts at
short a time on dialysis as possible, and to increase theyear end; the transplant rate was 8.7 pmp. The bulk of
availability of transplantation (both living related andcadaver donors are from the white and mixed race groups
cadaver). CAPD is currently an expensive treatment(21.9% of the population); following intensive public
modality in Africa. Efforts should be made to have theand media campaigns cadaver donors are very slowly
cost of CAPD fluids reduced, so that this treatment couldbeing retrieved from the black and Indian race groups.
be freely available in Africa. The use of CAPD in con-The registry has recently been re-established.
junction with an active transplant program is an appeal-Because of financial constraints, the National Health
ing strategy for Africa.Department, in consultation with nephrologists, has for-
Efforts should be made to optimize therapy of renalmalized a protocol for the management of end-stage
disease and renal failure globally and particularly in de-renal failure: state facilities will offer renal replacement
veloping countries. Strategies should be developed totherapy only to patients who are eligible for a transplant.
screen for and manage conditions such as hypertensionThere are no constraints of sex, race or social status;
and diabetes mellitus at the primary healthcare level indialysis is offered to transplantable patients who are able
an effort to decrease the incidence of chronic renal fail-to attend for treatment. The trade in organs is forbidden
ure. In areas where there are insufficient numbers ofby law in most countries in Africa. Transplantation of
physicians, nurses and other allied health workers couldorgans from living unrelated donors requires permission
be trained to manage these conditions at a local level,from the Minister of Health.
with clearly defined criteria for referral of patients. Pa-With the low transplant rate in South Africa, hemodi-
tients with renal disease should be referred to a nephrol-alysis units are saturated and it is becoming difficult to
ogist at an early stage so as to institute measures to retardaccommodate new patients unless they have a related
progression and plan timely transplantation and/or dial-donor or are able to undertake CAPD. Peritonitis and
ysis; this is particularly important where related donorsthe high costs of peritoneal dialysis fluids also limit this
may be available as a cost-effective strategy.option.
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